CDC advisory panel meets on J&J vaccine; April 14 call for clinicians
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices is holding an emergency meeting this afternoon on the Johnson & Johnson (Janssen) COVID-19 vaccine to review reports that six women aged 18-48 experienced a rare but serious condition involving blood clots and low platelets after receiving the vaccine.
Tomorrow at 2 p.m. ET, CDC will host a call for clinicians to discuss the latest evidence on these cases and any updated vaccine recommendations. CDC plans to post slides before the call and a replay after the event.
Related News Articles
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…